GlassScriptPhysician profile
Luke A Kinsinger
NPI 1407172836
$9,410.24
in general payments reported to CMS, 2019-2025
19 companies · $88.66 in 2025
The $88.66 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $119 · 2020: $107 · 2021: $137 · 2022: $405 · 2023: $7,868 · 2024: $685 · 2025: $88.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,524 · Travel and Lodging: $2,023 · Food and Beverage: $1,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,523.94 |
| Travel and Lodging | $2,022.68 |
| Food and Beverage | $1,095.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,791.56 | 2021-2023 | Davinci Xi, Da Vinci Surgical System |
| Medtronic, INC. | $626.23 | 2022-2024 | Ligasure, Sonicision, Signia |
| Davol INC. | $346.40 | 2022-2025 | Phasix Mesh |
| Ethicon US, LLC | $152.09 | 2020-2025 | Ethicon, Enseal |
| Heron Therapeutics, INC. | $74.25 | 2022-2024 | Zynrelef |
| Smith+Nephew, INC. | $61.81 | 2019-2022 | |
| Innocoll Pharmaceuticals Limited | $55.98 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021 | |
| Asensus Surgical, INC. | $38.61 | 2019 | |
| Dilon Technologies, INC. | $33.71 | 2025 | Hemoblast Bellows |
| Organogenesis INC. | $30.90 | 2024 | Puraply Am |
| Hologic Sales and Service, LLC | $26.51 | 2023 | Coolseal Generator |
| Merck Sharp & Dohme LLC | $24.42 | 2022 | |
| Csl Behring | $18.55 | 2019 | |
| Abbvie INC. | $17.40 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Checkpoint Surgical, INC | $16.31 | 2019 | |
| Boston Scientific Corporation | $15.40 | 2025 | Spyglass Discover |
| Tei Biosciences INC | $14.96 | 2019 | |
| Shire North American Group INC | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luke Kinsinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.